$IBO CO-founder to share his results at a global event
The company recently announced that DR Alberto Sola, CO-Founder of Universal Ibogaine, will present his recent findings in the title Ibogaine Hydrochloride and Acute Opioid Detox.
247.63 M
About UNIVERSAL IBOGAINE INC
Sector
Industry
CEO
Nicholas Peter Karos
Website
Headquarters
Calgary
Founded
2018
FIGI
BBG015MZ2LB4
Universal Ibogaine, Inc. engages in developing ibogaine based drug franchise to treat addiction and related mental health issues. The company was founded by Shayne Nyquvest and Alberto Solá Agulló in 2018 and is headquartered in Calgary, Canada.
Universal Ibogaine Inc.. Market InsightThe trading just got a green signal on the TSX-V, and $IBO zoomed past the fellow penny stocks in a flicker; what a scene it was; I am amazed and satisfied to buy some shares of it
$IBO is playing a fundamental role in the TSXV market Let’s go fellow shareholders of $IBO it is the day to be proud of yourself for trusting in $IBO, I am so enlivened to see this stock reaching the heights it was always meant to reach
Nick Karos jubilant by the listing of UI on Frankfurt stock exch
UI CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedeli
$IBO the apex stock in the market, waiting for your investment
$IBO is moving ahead with courage and compassion on the TSX-V, the stock is expanding in leaps and bounds in the market, shares are effectively trading at $0.0400 with zero loss percentage
$DIA stock stance and ticker review
$DIA has marked a rather brilliant opening on the TSX-V and is moving ahead with an unmatched pace and stock trading at suitable buying price of $0.1800 to generate heavy profit
$IBO on an unbelievable stock rally today on the TSX-V
$IBO don’t ever shy out from attaining peaks in the market and delivering unimaginable profit to the shareholders, the shares are trading yesterday with a massive spike of 10% at $0.0500 with sizeable ascent
Universal Ibogaine’s stock approved by borse Frankfurt
UI's common shares have been listed for trading on the Frankfurt Stock Exchange, or Bourse Frankfurt, under the ticker symbol "JC4". In Canada, UI will continue to trade on the TSX Venture Exchange under the ticker IBO and on the OTCQB under the ticker symbol IBOGF.
$IBO destined to be on top of the TSX-V index
$IBO is one of the handpicked penny stocks in the market today and is racing ahead with full speed, the stock’s financial figures are pretty neat and is expected achieve great heights in the days to come, shares are trading yesterday at $0.0500 with a distinctive spike
Perks handed to UI upon listing on the Frankfurt stock exchangeThe Frankfurt Stock Exchange (FSE) is Germany's largest stock exchange and the leading European destination for Canadian venture capital firms seeking exposure and liquidity in the European market. The FSE enables advanced electronic trading, settlement, and information technologies, allowing it to
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange UNIVERSAL IBOGAINE INC. stocks are traded under the ticker JC4.
Yes, you can track UNIVERSAL IBOGAINE INC. financials in yearly and quarterly reports right on TradingView.
No, JC4 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, JC4 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade UNIVERSAL IBOGAINE INC. stock right from TradingView charts — choose your broker and connect to your account.